Nusantics
Jakarta
About Nusantics
Nusantics is a precision molecular diagnostics startup from Indonesia; we develop PCR and Next Generation Sequencing-based solutions to improve healthcare outcomes in both human and animal applications. We offer 3 types of products; single pathogen molecular diagnostics, syndromic molecular diagnostics, and microbiome diagnostics (NGS)
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $2.2M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Sep 2022)
- Website: nusantics.com
- Phone: +62 21 50919430
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/nusantics-128783 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.